1.
Jensen CE, Heiling HM, Beke KE, Deal AM, Bryant AL, Coombs LA, Foster MC, Richardson DR. Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens. haematol [Internet]. 2023Apr.1 [cited 2024Nov.27];108(4):1006-14. Available from: https://haematologica.org/article/view/haematol.2022.280728